Detalhe da pesquisa
1.
Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.
J Infect Dis
; 219(11): 1799-1803, 2019 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30715452
2.
Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women.
Sex Transm Dis
; 46(10): 663-669, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31464859
3.
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.
Lancet Oncol
; 16(7): 775-86, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26071347
4.
Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study.
Hum Vaccin
; 7(12): 1374-86, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22048171
5.
Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
BMJ Open
; 6(8): e011371, 2016 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27566633
6.
Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA.
Clin Vaccine Immunol
; 22(2): 235-44, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25540273
7.
Efficacy and tolerability of a "suprabioavailable" formulation of fenofibrate in patients with dyslipidemia: a pooled analysis of two open-label trials.
Clin Ther
; 24(7): 1105-16, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12182255
8.
Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: results from a randomized study.
Hum Vaccin Immunother
; 10(5): 1155-65, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24576907
9.
A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
J Pain
; 12(2): 175-84, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21292168